An assessment of up- and down designs and associated estimators in phase I trials
From MaRDI portal
Publication:3498063
zbMATH Open1341.62313MaRDI QIDQ3498063FDOQ3498063
Authors: K. T. Ng, S. G. Mohanty, Narayanaswamy Balakrishnan
Publication date: 28 May 2008
Recommendations
- Design and Analysis of Phase I Clinical Trials
- A new look at evaluating MTD designs in cancer research
- The treatment versus experimentation dilemma in dose finding studies
- A method based on isotonic regression estimation for identifying the maximum tolerated dose
- scientific article; zbMATH DE number 590042
Applications of statistics to biology and medical sciences; meta analysis (62P10) Factorial statistical designs (62K15)
Cited In (8)
- A new look at evaluating MTD designs in cancer research
- Derivation of Exact Distributions Following an Up-and-Down Design
- Dose finding using the biased coin up-and-down design and isotonic regression
- Title not available (Why is that?)
- Up-and-down designs for dose-finding
- Design and Analysis of Phase I Clinical Trials
- Comparison of response rate estimators of anti-cancer drugs in two-stage designs
- A method based on isotonic regression estimation for identifying the maximum tolerated dose
This page was built for publication: An assessment of up- and down designs and associated estimators in phase I trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3498063)